Department of Basic Medical Science, School of Medicine, Tsinghua University, 100084, Beijing, China.
Tsinghua-Peking Joint Center for Life Sciences, Tsinghua University, 100084, Beijing, China.
Commun Biol. 2024 Nov 4;7(1):1432. doi: 10.1038/s42003-024-07048-x.
Identifying epitopes and their corresponding T-cell receptor (TCR) sequences is crucial in the face of rapidly mutating viruses. Peptide synthesis is often required to confirm the exact epitope sequences, which is time-consuming and expensive. In this study, we introduce a scalable workflow to identify the exact sequences of virus epitopes and reactive TCRs targeting the epitopes from memory T cells. Following the narrowing down of epitopes to specific regions via the tandem minigene (TMG) system, our workflow incorporates the utilization of peptide-major histocompatibility complex-displaying yeasts (pMHC-displaying yeasts) to rapidly screen immunogenic epitopes' precise sequences, obviating the necessity for the chemical synthesis of peptides. Focusing on SARS-CoV-2, we identify the precise sequences of reactive TCRs, targeting conserved epitopes across the Coronaviridae family, from the blood of COVID-19-recovered individuals over 8 months. Notably, we reveal that at least 75% (6/8) of the tested donors harbor T cells targeting a shared epitope, KTFPPTEPK, derived from the N protein. Furthermore, several identified TCRs exhibit cross-reactivity to mutant epitopes, suggesting a potential mechanism for sustained T-cell responses against emerging SARS-CoV-2 variants.
在面对快速变异的病毒时,鉴定表位及其相应的 T 细胞受体(TCR)序列至关重要。通常需要进行肽合成来确认确切的表位序列,这既耗时又昂贵。在这项研究中,我们引入了一种可扩展的工作流程,用于从记忆 T 细胞中鉴定针对表位的病毒表位和反应性 TCR 的精确序列。在通过串联小基因(TMG)系统将表位缩小到特定区域后,我们的工作流程包括利用肽-主要组织相容性复合物展示酵母(pMHC 展示酵母)来快速筛选免疫原性表位的精确序列,从而避免了肽的化学合成的必要性。本研究聚焦于 SARS-CoV-2,我们从 COVID-19 康复者的血液中,在 8 个月的时间内鉴定出了针对冠状病毒科保守表位的反应性 TCR 的精确序列。值得注意的是,我们发现至少 75%(6/8)的测试供体具有靶向 N 蛋白衍生的共有表位 KTFPPTEPK 的 T 细胞。此外,一些鉴定出的 TCR 表现出对突变表位的交叉反应性,这表明针对不断出现的 SARS-CoV-2 变体持续 T 细胞反应的潜在机制。